284 related articles for article (PubMed ID: 20354682)
41. Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23.
Wu W; Fan H; Jiang Y; Liao L; Li L; Zhao J; Zhang H; Shrestha C; Xie Z
Exp Dermatol; 2018 Nov; 27(11):1201-1209. PubMed ID: 30066343
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanisms of cadmium-induced fibroblast growth factor 23 upregulation in osteoblast-like cells.
Kido S; Fujihara M; Nomura K; Sasaki S; Mukai R; Ohnishi R; Kaneko I; Segawa H; Tatsumi S; Izumi H; Kohno K; Miyamoto K
Toxicol Sci; 2014 Jun; 139(2):301-16. PubMed ID: 24614234
[TBL] [Abstract][Full Text] [Related]
43. The local production of 1,25(OH)2D3 promotes osteoblast and osteocyte maturation.
Turner AG; Hanrath MA; Morris HA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():114-8. PubMed ID: 24125735
[TBL] [Abstract][Full Text] [Related]
44. Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts.
Saito H; Nakamachi T; Inoue K; Ikeda R; Kitamura K; Minamino N; Shioda S; Miyata A
J Endocrinol; 2013 May; 217(2):141-50. PubMed ID: 23428580
[TBL] [Abstract][Full Text] [Related]
45. Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.
Koshihara Y; Hoshi K; Ishibashi H; Shiraki M
Calcif Tissue Int; 1996 Dec; 59(6):466-73. PubMed ID: 8939773
[TBL] [Abstract][Full Text] [Related]
46. [Bone and Nutrition. The vitamin D functions in osteoblasts and osteocytes].
Sawatsubashi S
Clin Calcium; 2015 Jul; 25(7):991-7. PubMed ID: 26119311
[TBL] [Abstract][Full Text] [Related]
47. An in vitro Experimental Insight into the Osteoblast Responses to Vitamin D3 and Its Metabolites.
Wang D; Song J; Ma H
Pharmacology; 2018; 101(5-6):225-235. PubMed ID: 29393236
[TBL] [Abstract][Full Text] [Related]
48. Species difference exists in the effects of 1alpha,25(OH)(2)D(3) and its analogue 2-methylene-19-nor-(20S)-1,25-dihydroxyvitamin D(3) (2MD) on osteoblastic cells.
Li Y; Bäckesjö CM; Haldosén LA; Lindgren U
J Steroid Biochem Mol Biol; 2008 Nov; 112(1-3):110-6. PubMed ID: 18832035
[TBL] [Abstract][Full Text] [Related]
49. In vitro regulation of fibroblast growth factor 23 by 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D synthesized by osteocyte-like MC3T3-E1 cells.
Ratsma DMA; Muller M; Koedam M; Zillikens MC; van der Eerden BCJ
Eur J Endocrinol; 2023 Oct; 189(4):448-459. PubMed ID: 37796032
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D sterols increase FGF23 expression by stimulating osteoblast and osteocyte maturation in CKD bone.
Pereira RC; Salusky IB; Bowen RE; Freymiller EG; Wesseling-Perry K
Bone; 2019 Oct; 127():626-634. PubMed ID: 31377240
[TBL] [Abstract][Full Text] [Related]
51. Regulation of the 1b isoform of the plasma membrane calcium pump by 1,25-dihydroxyvitamin D3 in rat osteoblast-like cells.
Glendenning P; Ratajczak T; Dick IM; Prince RL
J Bone Miner Res; 2001 Mar; 16(3):525-34. PubMed ID: 11277270
[TBL] [Abstract][Full Text] [Related]
52. The human analog of murine cystein rich protein 61 [correction of 16] is a 1alpha,25-dihydroxyvitamin D3 responsive immediate early gene in human fetal osteoblasts: regulation by cytokines, growth factors, and serum.
Schütze N; Lechner A; Groll C; Siggelkow H; Hüfner M; Köhrle J; Jakob F
Endocrinology; 1998 Apr; 139(4):1761-70. PubMed ID: 9528960
[TBL] [Abstract][Full Text] [Related]
53. Effects of 25-hydroxyvitamin D(3) on proliferation and osteoblast differentiation of human marrow stromal cells require CYP27B1/1α-hydroxylase.
Geng S; Zhou S; Glowacki J
J Bone Miner Res; 2011 May; 26(5):1145-53. PubMed ID: 21542014
[TBL] [Abstract][Full Text] [Related]
54. Targeted disruption of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in ras-transformed keratinocytes demonstrates that locally produced 1alpha,25-dihydroxyvitamin D3 suppresses growth and induces differentiation in an autocrine fashion.
Huang DC; Papavasiliou V; Rhim JS; Horst RL; Kremer R
Mol Cancer Res; 2002 Nov; 1(1):56-67. PubMed ID: 12496369
[TBL] [Abstract][Full Text] [Related]
55. Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor.
Yashiro M; Ohya M; Mima T; Nakashima Y; Kawakami K; Yamamoto S; Kobayashi S; Yano T; Tanaka Y; Sonou T; Tatsuta K; Negi S; Shigematsu T
J Pharm Biomed Anal; 2020 Apr; 182():113139. PubMed ID: 32045827
[TBL] [Abstract][Full Text] [Related]
56. Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.
Shimada T; Kakitani M; Yamazaki Y; Hasegawa H; Takeuchi Y; Fujita T; Fukumoto S; Tomizuka K; Yamashita T
J Clin Invest; 2004 Feb; 113(4):561-8. PubMed ID: 14966565
[TBL] [Abstract][Full Text] [Related]
57. Glucocorticoids dexamethasone and prednisolone suppress fibroblast growth factor 23 (FGF23).
Feger M; Ewendt F; Strotmann J; Schäffler H; Kempe-Teufel D; Glosse P; Stangl GI; Föller M
J Mol Med (Berl); 2021 May; 99(5):699-711. PubMed ID: 33517471
[TBL] [Abstract][Full Text] [Related]
58. Attenuated Dentin Matrix Protein 1 Enhances Fibroblast Growth Factor 23 in Calvaria in a Primary Hyperparathyroidism Model.
Nagata Y; Imanishi Y; Ohara M; Maeda-Tateishi T; Miyaoka D; Hayashi N; Kurajoh M; Emoto M; Inaba M
Endocrinology; 2019 May; 160(5):1348-1358. PubMed ID: 30916761
[TBL] [Abstract][Full Text] [Related]
59. Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model.
Sugiura H; Matsushita A; Futaya M; Teraoka A; Akiyama KI; Usui N; Nagano N; Nitta K; Tsuchiya K
PLoS One; 2018; 13(3):e0191706. PubMed ID: 29518087
[TBL] [Abstract][Full Text] [Related]
60. 1,25 dihydroxyvitamin-D3 attenuates the confluence-dependent differences in the osteoblast characteristic proteins alkaline phosphatase, procollagen I peptide, and osteocalcin.
Siggelkow H; Schulz H; Kaesler S; Benzler K; Atkinson MJ; Hüfner M
Calcif Tissue Int; 1999 May; 64(5):414-21. PubMed ID: 10203418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
